One study hypothesized that loss of USP9X (seen in 4/17 CRLF2-rearranged cases), which encodes a deubiquitinase known to stabilize activated JAK2, may naturally buffer the toxic effect of JAK/STAT signaling hyperactivation in DS–ALL [67]. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.